Mauger Florence, Tost Jörg
Laboratory for Epigenetics & Environment, Centre National de Recherche en Génomique Humaine, CEA-Institut de Biologie François Jacob, Evry, France.
Bio Protoc. 2019 Dec 5;9(23):e3452. doi: 10.21769/BioProtoc.3452.
In the context of precision medicine, the identification of novel biomarkers for the diagnosis of disease, prognosis, predicting treatment outcome and monitoring of treatment success is of great importance. The analysis of methylated circulating-cell free DNA provides great promise to complement or replace genetic markers for these applications, but is associated with substantial challenges. This is particularly true for the detection of rare methylated DNA molecules in a limited amount of sample such as tumor released hypermethylated molecules in the background of DNA fragments from normal cells, especially lymphocytes. Technologies for the sensitive detection of DNA methylation have been developed to enrich specifically methylated DNA or unmethylated DNA using among other methods: enzymatic digestion, methylation-specific PCR (often combined with TaqMan like oligonucleotide probes (MethyLight)) and co-amplification at lower denaturation temperature PCR (COLD-PCR). E--COLD-PCR (Enhanced-improved and complete enrichment-COLD-PCR) is a sensitive method that takes advantage of a Locked Nucleic Acid (LNA)-containing oligonucleotide probe to block specifically unmethylated CpG sites allowing the strong enrichment of low-abundant methylated CpG sites from a limited quantity of input. E--COLD-PCRs are performed on bisulfite-converted DNA followed by Pyrosequencing analysis. The quantification of the initially present DNA methylation level is obtained using calibration curves of methylated and unmethylated DNA. The E--COLD-PCR reactions can be multiplexed, allowing the analysis and quantification of the DNA methylation level of several target genes. In contrast to the above-mentioned assays, E--COLD-PCR will also perform in the presence of frequently occurring heterogeneous DNA methylation patterns at the target sites. The presented protocol describes the development of an E--COLD-PCR assay including assay design, optimization of E--COLD-PCR conditions including annealing temperature, critical temperature and concentration of LNA blocker probe followed by Pyrosequencing analysis.
在精准医学背景下,鉴定用于疾病诊断、预后评估、预测治疗结果及监测治疗成功与否的新型生物标志物至关重要。甲基化循环游离DNA的分析为补充或替代这些应用中的遗传标志物带来了巨大希望,但也伴随着诸多重大挑战。对于在有限样本量中检测罕见的甲基化DNA分子而言尤其如此,比如在来自正常细胞(尤其是淋巴细胞)的DNA片段背景下肿瘤释放的高甲基化分子。已开发出用于灵敏检测DNA甲基化的技术,可使用多种方法特异性富集甲基化DNA或未甲基化DNA,这些方法包括:酶切、甲基化特异性PCR(通常与TaqMan类似的寡核苷酸探针(MethyLight)结合)以及低温变性温度PCR共扩增(COLD-PCR)。E-COLD-PCR(增强改进型完全富集COLD-PCR)是一种灵敏的方法,它利用含锁核酸(LNA)的寡核苷酸探针特异性阻断未甲基化的CpG位点,从而能够从有限量的输入样本中强力富集低丰度的甲基化CpG位点。E-COLD-PCR是在亚硫酸氢盐转化的DNA上进行,随后进行焦磷酸测序分析。使用甲基化和未甲基化DNA的校准曲线来获得初始存在的DNA甲基化水平的定量。E-COLD-PCR反应可以进行多重分析,从而能够分析和定量多个靶基因的DNA甲基化水平。与上述检测方法不同,E-COLD-PCR在靶位点存在频繁出现的异质性DNA甲基化模式时也能发挥作用。本文介绍的方案描述了E-COLD-PCR检测方法的开发,包括检测方法设计、E-COLD-PCR条件的优化,如退火温度、临界温度和LNA阻断探针的浓度,随后进行焦磷酸测序分析。